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Background: Malaria, trypanosomiasis and leishmaniasis have an overwhelming impact in the poorest countries in the
world due to their prevalence, virulence and drug resistance ability. Currently, there is inadequate armory of drugs for
the treatment of malaria, trypanosomiasis and leishmaniasis. This underscores the continuing need for the discovery
and development of new anti-protozoal drugs. Consequently, there is an urgent need for research aimed at the
discovery and development of new effective and safe anti-plasmodial, anti-trypanosomal and anti-leishmanial drugs.
Methods: Bioassay-guided chromatographic fractionation was employed for the isolation and purification of
antiprotozoal alkaloids.
Results: The methanol extract from the leaves of Annickia kummeriae from Tanzania exhibited a strong anti-plasmodial
activity against the multi-drug resistant Plasmodium falciparum K1 strain (IC50 0.12 ± 0.01 μg/ml, selectivity index (SI)
of 250, moderate activity against Trypanosoma brucei rhodesiense STIB 900 strain (IC50 2.50 ± 0.19 μg/ml, SI 12) and mild
activity against Leishmania donovani axenic MHOM-ET-67/82 strain (IC50 9.25 ± 0.54 μg/ml, SI 3.2). Bioassay-guided
chromatographic fractionation led to the isolation of four pure alkaloids, lysicamine (1), trivalvone (2), palmatine
(3), jatrorrhizine (4) and two sets of mixtures of jatrorrhizine (4) with columbamine (5) and palmatine (3) with
(−)-tetrahydropalmatine (6). The alkaloids showed low cytotoxicity activity (CC50 30 - >90 μg/ml), strong to moderate
anti-plasmodial activity (IC50 0.08 ± 0.001 - 2.4 ± 0.642 μg/ml, SI 1.5-1,154), moderate to weak anti-trypanosomal
(IC50 2.80 ± 0.001 – 14.3 ± 0.001 μg/ml, SI 2.3-28.1) and anti-leishmanial activity IC50 2.7 ± 0.001 – 20.4 ± 0.003 μg/ml,
SI 1.7-15.6).
Conclusion: The strong anti-plasmodial activity makes these alkaloids good lead structures for drug development
programs.
Keywords: Annickia kummeriae, Enantia kummeriae, Annonaceae, Alkaloids, Aporphine, Protoberberine, Antiplasmodial,
Antitrypanosomal, Antileishmanial, CytotoxicityBackground
Protozoal diseases such as malaria, trypanosomiasis and
leishmaniasis have an overwhelming impact in the
poorest countries in the world [1]. Due to their preva-
lence, virulence and drug resistance, they are the most
serious and widespread parasitic diseases in the tropics
[1-5]. The inadequate armory of drugs for the treatment* Correspondence: Malebo@hotmail.com
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reproduction in any medium, provided the orof malaria, trypanosomiasis and leishmaniasis; and the
high cost of new drugs coupled with the rapid develop-
ment of resistance to new anti-parasitic drugs are some
of the limiting factors in the fight against these tropical
diseases. This underscores the continuing need for the
discovery and development of new anti-protozoal drugs.
Consequently, there is an urgent need for research
aimed at the discovery and development of new effective
and safe anti-plasmodial, anti-trypanosomal and anti-
leishmanial drugs. In view of the complicated situations
in dealing with parasitic infections, chemotherapyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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development of new drugs, the plant kingdom is con-
sidered to be important source for lead compounds
owing to the successful use in traditional treatment of
various ailments since antiquity [6]. Historically, medi-
cinal plants have served as sources of new pharmaceutical
products like quinine and artemisinin [7] and inexpensive
starting materials for the synthesis of many known drugs.
Research focused on the identification of medicinal
natural products from higher plants for the discovery of
new parasitic agents has been ongoing for more than five
decades.
Ethnomedical information revealed that several Annickia
(formerly Enantia) species are used widely for the treat-
ment of malaria and other ailments [8]. Enantia chlorantha
and E. polycarpa are used traditionally in the treatment of
malaria and fever in West and Central Africa [9,10]. Con-
sequently, previous pharmacological investigations on
genus Enantia revealed promising anti-protozoal activity
with the stem-bark extract of E. chlorantha showing
strong in vitro anti-plasmodial activity against P. falci-
parum K1 strain (IC50 0.126 μg/ml) and good selectivity
(SI 616) [11]. Furthermore, E. chlorantha aqueous and
ethanolic extracts exhibited in vivo activity with ED50
values of 6.9 mg g-1 and 0.34 mg g-1, respectively, against
Plasmodium yoelii in experimentally infected mice [12].
The chemistry of E. chlorantha and E. polycarpa has been
extensively studied [10,13-15]. Several quinoline and
isoquinoline alkaloids including protoberberines,
quinine and dihydroquinidine have been isolated from
E. polycarpa [16,17]. Protoberberine alkaloids have
been identified as the major anti-protozoal alkaloids
in E. chlorantha and E. polycarpa [16-19]. Protoberberines
isolated from Enantia chlorantha exhibited significant
antiplasmodial activity against both CQ-sensitive and re-
sistant strains of P. falciparum: palmatine (3) (IC50 0.27
and 0.16 μg/ml, respectively) and jatrorrhizine (4)
(IC50 4.2 and 1.61 μg/ml, respectively) in vitro [18]. A
mixture of protoberberine alkaloids from Enantia
chlorantha containing; palmatine (3), jatrorrhizine (4) and
columbamine (5) (Hepasor), were shown to prevent liver
injury from chemically induced traumatization and also
promoted the healing process after the injury [20] in
experimental mice. Palmatine (3) and jatrorrhizine (4)
demonstrated to inhibit the growth of Babesia gibsoni at
concentrations ranging from 100 and 10 μg/ml [21]. In an
effort to identify the molecular basis of activity, we under-
took bioassay-guided fractionation of extracts of Annickia
kummeriae (Engl. & Diels) Setten & Maas (formerly,
Enantia kummeriae), a plant traditionally used for the
treatment of malaria in Tanzania. Bioassay-guided chro-
matography led to the isolation of lysicamine (1),
trivalvone (2), palmatine (3), jatrorrhizine (4) and two sets
of mixtures of jatrorrhizine (4) with columbamine (5) andpalmatine (3) with (−)-tetrahydropalmatine (6) as shown
in Figure 1.
Methods
General procedures
Analytical grade and double-distilled solvents were used
for the extraction and chromatographic isolation and
purification of compounds. Analytical thin layer chroma-
tography (TLC) was performed on both aluminium and
plastic sheets precoated with silica gel 60 F254 (Merck)
with a 0.2 mm layer thickness. Visualisation of TLC
spots was carried out under UV light at 254 or 366 nm
and by spraying with Dragendorff reagent. Preparative
thin layer chromatography (PTLC) was done using normal
phase silica gel 60 F254 (Merck) precoated on glass plates
(20 × 20 cm), with varying thickness (0.5, 1.0 or 2.0 mm).
Detection was done under UV light at 254 or 366 nm.
Preparative high speed counter-current chromatograph
(HSCCC) was done on Potomac (P.C. Inc., Buffalo, NY-
USA) equipped with three preparative multilayer coils
(wound with 1.7 mm internal diameter, polytetrafluoro-
ethylene PTFE tubing of 80 ml and 240 ml connected in
series with a total capacity of 320 ml) run at a revolution
speed of 611 rpm and the solvent was pumped into the
column with a Büchi B-688 chromatography pump. Con-
tinuous monitoring of the effluent was achieved with a
Model UV-II detector Monitor at 254 nm. A manual sam-
ple injection valve with a 20 mL loop was used to intro-
duce the sample into the column and the eluent collected
in a Büchi B-684 fraction collector. Melting points of
recrystallized solids were measured on a Büchi B-540
apparatus and are uncorrected. IR spectra were measured
on a Perkin Elmer model 1600 FT-IR spectrophotometer
using potassium bromide pellets. Mass spectra were
measured on mass spectrometer VG 70S (EIMS) and a
Finnigan MAT 312 FABMS. NMR spectra were measured
on Bruker Avance 400 (1H NMR 400 MHz; 13C NMR
101 MHz), Bruker VRX 500 (1H NMR 500 MHz; 13C
NMR 125 MHz) and Bruker DRX 600 (1H NMR
600 MHz; 13C NMR 150.9 MHz). The purity level was
determined by LC-MS (Agilent 1100 system equipped
with an Agilent 1100 DAD MS detector; column
Nucleodur C18, 5 μm, 125 mm× 4.0 mm internal diameter
(i.d); mobile phase A: 0.01% aqueous formic acid and mo-
bile phase B: acetonitrile). The structures were assigned by
NMR and mass spectrometry. The isolated compounds
were screened for anti-plasmodial, anti-trypanosomal,
anti-leishmanial and cytotoxic activity.
Plant materials and chemicals
Plant materials were collected at Amani Nature Reserve
(Tanzania) in August 2003 and identified at the Depart-
ment of Botany, University of Nairobi (Kenya) where the
voucher specimen (HM 2004/04) is deposited in the
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Figure 1 Chemical structures of isolated compounds.
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stem-bark) were dried under shade for 14 days and
ground to powder. The ground air-dried Annickia
kummeriae leaves, stem and root bark (1.12, 1.55 and
1.77 kg, respectively) were extracted sequentially, at
room temperature for 48 hours with intermittent
shaking, with petroleum ether (PE), dichloromethane
(DCM) and methanol (MeOH). The extract was
filtered off, the solvent removed under reduced pres-
sure at 30°C, dried further under a stream of nitrogen for
24 hours before being weighed and used for biological
assays.
Chemicals used were: Formic acid, hydrochloric acid,
sulphuric acid, acetic acid, citric acid, p-anisaldehyde,
vanillin, dragendorf reagent, sodium chloride, sodium
hydrogen carbonate, acetone, n-hexane, petroleum ether,
dichloromethane, chloroform, ethyl acetate, toluene,
ethanol and methanol were also bought from Kobian
Chemicals, Nairobi, Kenya and Fluka AG in Switzerland.
Analytical grade or double-distilled solvents were used
for the extraction and chromatographic isolation and
purification of compounds. [3H]-Hypoxanthine and
Rosewell Park Memorial Institute 1640 (RPMI 1640)
powdered medium were bought from Gibco Laborator-
ies, California, U.S.A whereas, dextrose, Giemsa stain,
resazurin dye, glycerol and N-2-hydroxyethylpiperazine
N-2-ethanesulfonic acid (HEPES) were bought from
Sigma-Aldrich, Germany. Deuterated solvents: chloroformand methanol used for spectroscopic analysis were bought
from Fluka AG, Switzerland.
Bioassay of extracts and guided isolation of aporphine
and protoberberine alkaloids
In vitro anti-plasmodial assay
Anti-plasmodial activity was evaluated against the multi-
drug resistant Plasmodium falciparum K1 strain (resistant
to chloroquine and pyrimethamine), using the parasite
cultivation method of Trager and Jensen, 1976 [22] and
the assay originally described by Desjardins et al., 1979
[23] with slight modifications by Matile & Pink [24].
In vitro anti-trypanosomal assay
The in vitro anti-trypanosomal activity was evaluated
against Trypanosoma brucei rhodesiense STIB 900 strain,
using the cultivation method of Baltz et al.,1985 [25]
whereby the Minimum Essential Medium (MEM) was
supplemented with 0.2 mM 2-mercaptoethanol, 1 mM
sodium pyruvate, 0.5 mM hypoxanthine and 15% heat-
inactivated horse serum. The assay was performed
according to Räz et al., 1997 [26].
In vitro anti-leishmanial assay
The in vitro anti-leishmanial assay was carried out
against axenic amastigote forms of Leishmania donovani
MHOM-ET-67/82 strain according to the procedure
described by Ganapaty et al., 2006 [27].
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The in vitro cytotoxicity assay was carried out using rat
skeletal myoblast (L-6) cells according to the procedure
described by Ganapaty et al., 2006 [27]. Cytotoxicity
activity of the test extract and compounds (IC50) was
compared with cytotoxicity activity of the standard
cytotoxic compound and used to calculate selectivity
index. Selectivity indices (SI) were calculated using the
formula:
SI ¼ Cytotoxicity of standard drug CC50ð Þ
Cytotoxicity of test extract=compound IC50ð Þ
Bioassay guided isolation of antiplasmodial compounds
The ground air-dried leaves, stem bark and root bark of
Annickia kummeriae (1.12 kg, 1.55 kg and 1.77 kg, respec-
tively) was extracted sequentially with solvents of increasing
polarity (petroleum ether, dichloromethane and metha-
nol) for 48 hours at room temperature. The resulting
extracts were obtained by filtration and concentration
in vacuo at 30°C. After screening for anti-plasmodial,
anti-trypanosomal, anti-leishmanial and cytotoxic acti-
vity, the crude methanolic leaf extract, which was the
most active, was selected for bioassay-guided fractio-
nation and isolation of anti-protozoal compounds. The
methanolic leaf extract (3 g) was fractionated using
HSCCC through stepwise elution with a biphasic solvent
system (CHCl3:MeOH:0.2 M HCl 7:3:4, v/v/v) to yield 17
fractions which were screened for anti-plasmodial and
cytotoxic activity. The HSCCC fractions AKLM 4-AKLM
6 and AKLM 7-AKLM 10, which exhibited anti-
plasmodial activity, were combined based on similarity of
the TLC profile. Repeated HSCCC of fraction AKLM 2
using stepwise elution with a biphasic solvent system
(CHCl3:MeOH:0.2 M HCl 7:3:4) gave 11 sub-fractions
(AKLM 1-AKLM 11) which were screened for anti-
plasmodial and cytotoxic activity. Column chromatog-
raphy of sub-fractions AKLM 2.10 and AKLM 2.11 on
silica gel (0.040–0.063 mm) eluting with C6H14-EtOAc 1:1,
and EtOAc-MeOH 8:2 followed by purification with
sephadex LH-20 eluting with MeOH-CHCl3 1:1 and pre-
parative TLC (PTLC) on silica gel PF254 with CHCl3:
MeOH:HCO2H 98:1.8:0.2 yielded (10.21 mg) of lysicamine
(1) ( 0.01% yield, 92% purity) and (8.10 mg) of trivalvone
(2) (0.01% yield:, 95% purity), respectively. Repeated
HSCCC eluting with CHCl3:MeOH:0.2 M HCl 7:3:4 of the
combined fractions AKLM 7-AKLM 10 gave 20 sub-
fractions (AKLM 7.1-AKLM 7.20). TLC analysis indicated
a similar pure compound in AKLM 7.6-AKLM 7.13
which was recrystallized from methanol to yield (1.52 g) of
palmatine (3) (1.84% yield, 91% purity). Column
chromatography (silica gel 0.040–0.063 mm) of sub-
fractions AKLM 7.15-AKLM 7.16, with similar TLCprofiles, eluting sequentially with CHCl3:MeOH:HCO2H
9:0.75:0.25, 8:1.75:0.25, 6:3.75:0.5 and 5:4.5:0.5 followed by
recrystallization from methanol yielded (40.82 mg) of
jatrorrhizine (4) (0.05% yield, 94% purity). Repeated
HSCCC of of the combined fractions AKLM 4-AKLM 6
with CHCl3:MeOH:0.2 M HCl 7:3:4 gave 16 sub-fractions
(AKLM 4.1-AKLM 4.16). Column chromatography (silica
gel 0.040–0.063 mm) with MeOH;CH2Cl2:HCO2H 4:15:1
followed by PTLC (silica gel PF254) with MeOH-CH2Cl2-
HCO2H 5:14:1 gave (34.2) of an inseparable mixture
(1.2:1.0) of jatrorrhizine (4) and columbamine (5) (0.04%
yield). Similarly, HSCCC of of AKLM 16 with CHCl3:
MeOH:0.2 M HCl 7:3:4 gave 12 sub-fractions (AKLM
16.1-AKLM 16.12). Column chromatography (silica gel
0.040–0.063 mm) of the combined sub-fractions AKLM
16.8-AKLM 16.10 with MeOH;CH2Cl2;HCO2H 5:14:1
followed by PTLC (silica gel PF254) with MeOH:CH2Cl2-
HCO2H 4:15:1 yielded (28.2 mg) of an inseparable mixture
(1.1:1.0) of palmatine (3) and (−)-tetrahydropalmatine (6)
(0.03% yield).
Structural elucidation of isolated compounds
The chemical structures of isolated compounds were
established on the basis of spectroscopical data as Infra-
red (IR), 1D (1H, 13C, DEPT 135) and 2D-NMR
experiments; Heteronuclear Multiple-Quantum Correl-
ation (HMQC), correlation spectroscopy (COSY) and
Heteronuclear Multiple Bond Correlation (HMBC) plus
Mass Spectroscopy (MS) data. The 13C NMR data were
assigned with the help of HMQC and DEPT 135
experiments while, the connectivity’s of the molecular
fragments were established by HMBC, COSY and NOESY.
The analysis of the spectra and structure elucidation was
also facilitated by comparison of observed and published
1H and 13C NMR data for the compounds.
Lysicamine (1): yellow needles (10.21 mg), m.p. 209–211°C,
1H NMR (CDCl3, 600 MHz) δ 7.57 (1H, s, H-3), 8.07 (1H,
d, J= 5.2 Hz, H-4), 8.77 (1H, d, J = 5.2 Hz, H-5), 8.48 (1H,
dd, J= 9.0, 1.8 Hz, H-8), 7.63 (1H, t, J= 9.0, 1.2 Hz, H-9),
7.86 (1H, t, J = 9.0, 1.4 Hz, H-10), 9.26 (1H, dd, J = 9.0,
1.2 Hz, H-11), 4.13 (3H, s, 1-OCH3), 4.06 (3H, s, 2-OCH3).
13C NMR (CDCl3, 600 MHz) δ 145.3 (s, C-1), 158.2 (s, C-2),
108.3 (d, C-3), 157.5 (s, C-3a), 125.8 (s, C-4), 145.0
(d, C-5), 155.6 (s, C-6a), 123.3 (s, C-6b), 182.6 (s, C-7),
132.8 (s, C-7a), 129.3 (d, C-8), 129.8 (d, C-9), 135.7
(d, C-10), 129.7 (s, C-11), 135.8 (s, 11a), 120.0 (s, 11b),
60.1 (q, 1- OCH3), 56.4 (q, 1- OCH3). MS: m/z 291 (100%),
275 (15%), 248 (84%), 233 (9%), 188 (4%), 177 (12%). The
molecular mass of 1 is m/z 291 amu which is consistent
with the formula C18H13NO3. All the data for compound
1 were consistent with the reported values for lysicamine,
which was first isolated from Lysichiton camtschatcense
(Araceae) [28,29]. Lysicamine (1) has been widely
isolated from several plant species [30] however; this is
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A. kummeriae (Annonaceae).
Trivalvone (2): brown crystals (8.10 mg), m.p. 256-
258°C), 1H NMR (CDCl3, 500 MHz) δ 6.87 (1H, s, H-3),
7.54 (1H, d, J = 4.1, H-4), 8.90 (1H, d, J = 4.1, H-5), 7.76
(1H, d, J = 9.0, 2.1, H-8), 7.35 (1H, t, J = 9.0, 2.1, H-9),
7.85 (1H, t, J = 9.0, 2.1, H-10), 10.20 (1H, d, J = 9.0,
2.1 H-11), 7.18 (1H, s, H-3´), 2.95 (2H, m, H-4´), 3.26
(2H, m, H-5´), 6.70 (1H, d, H-8´), 7.12 (1H, t, H-9´),
7.43 (1H, t, H-10´), 9.75 (1H, d, H-11´), 4.07 (3H, s, 2-
OCH3), 4.01 (3H, s, 1´ -OCH3), 4.07 (3H, s, 2´ -OCH3), 2.15
(3H, s, 1´ - N-CH3).
13C NMR (CDCl3, 500 MHz) δ 181.0
(s, C-1), 151.3 (s, C-2), 107.5 (d, C-3), 127.9 (d, C-3a),
127.9 (d, C-4), 151.0 (d, C-5), 156.6 (s, C-6a), 122.6 (s, C-6b),
134.0 (s, C-7), 142.5 (s, C-7a), 132.6 (d, C-8), 128.7
(d, C-9), 127.0 (d, C-10), 121.9 (d, C-11), 122.7 (s, C-11a),
136.2 (s, C-11b), 145.9 (s, C-1´), 150.6 (s, C-2´), 112.8
(d, C-3´), 130.9 (s, C-3´ a), 25.6 (t, C-4´), 49.7 (t, C-5´ ),
143.8 (s, C-6´ a), 121.1 (s, C-6´ b), 122.4 (s, C-7´), 134.4
(s, C-7´ a), 127.9 (d, C-8´), 126.7 (d, C-9´), 126.6 (d, C-10´),
124.7 (d, C-11´), 126.2 (s, C-11´ a), 127.4 (s, C-11´ b), 56.3
(q, 2-OCH3), 60.0 (q, 1΄ -OCH3), 56.6 (q, 2΄ -OCH3), 41.6
(q, N-CH3). MS: m/z 554 ([M + 2]
+, 90.4%), 553 ([M + 1]+,
41.3%), 292 (M/2 +H, 8.4%).
The molecular mass of 2 is m/z 552 amu, which is
consistent with the formula C36H28N2O4. The absence
of any fragmentation in the region m/z 552–292
suggested a dimeric structure for 2, resulting from a
C-7→C-7´ oxidative coupling between the two aporphine
units [31]. The NMR and MS data confirmed the structure
of the bis-aporphine alkaloid, trivalvone (2), a rare alkaloid
first reported in 1990 from Trivalvaria macrophylla
(Annonaceae) [31] and subsequently from Piptostigma
fugax (Annonaceae) [32]. This is the first report on the
presence of trivalvone (2) from Annickia kummeriae
(Annonaceae).
Palmatine (3): yellow solid (1.52 g), m.p. 203–205°C,
1H NMR (CD3OD, 500 MHz) δ 7.63 (1H, s, H-1), 7.04
(1H, s, H-4), 3.30 (2H, t, J = 6.3, H-5), 4.95 (2H, t, J = 6.3,
H-6), 9.75 (1H, br, s, H-8), 8.09 (1H, d, J = 9.1, H-11),
8.01 (1H, d, J = 9.1, H-12), 8.79 (1H, s, H-13), 3.94 (3H,
s, 2-OCH3), 4.00 (3H, s, 3-OCH3), 4.22 (3H, s, 9-OCH3),
4.10 (3H, s, 10-OCH3).
13C NMR (CD3OD, 500 MHz) δ
110.4 (d, C-1), 151.3 (s, C-2), 154.2 (s, C-3), 112.7 (d, C-4),
130.4 (s, C-4a), 28.2 (t, C-5), 56.4 (t, C-6), 146.7 (d, C-8), 123.6
(s, C-8a), 146.1 (s, C-9), 152.3 (d, C-10), 128.4 (d, C-11), 124.9
(d, C-12), 135.6 (s, C-12a), 121.7 (d, C-13), 140.1 (s, C-13a),
120.8 (s, C-13b), 57.5 (q, 2-OCH3), 57.1 (q, 3-OCH3), 63.0
(q, 9-OCH3), 57.8 (q, 10-OCH3). MS: m/z 352 (75%), 337
(6%), 336 (7%), 308 (20%), 154 (100%), 77 (25%), 39
(20%). The mass spectrum of 3 exhibited a molecular
ion peak at m/z 352, which is consistent with the for-
mula C21H22NO4
+ (D.B.E 11.5). The non-integer value
of the index of hydrogen deficiency suggested that 3could be a quaternary ammonium salt consistent with
palmatine (3). All the observed data for 3 were consistent
with the reported values for palmatine except for the inter-
change of H-11 and H-12 in 1H NMR [33,34]. Palmatine (3)
has been previously reported from many plant families:
Papaveraceae, Berberidaceae, Fumariaceae, Menispermaceae,
Ranunculaceae, Rutaceae, Annonaceae, Magnoliaceae
and Convolvulaceae [35].
Jatrorrhizine (4): orange crystals (40.82 mg), m.p.
204–206°C, 1H NMR (CDCl3, 600 MHz) δ 7.57 (1H, s,
H-1), 6.76 (1H, s, H-4), 3.17 (2H, t, J = 6.1 Hz, H-5), 4.87
(2H, t, J = 6.1 Hz, H-6), 9.67 (1H, t, br, s, H-8), 8.07 (1H, d,
J = 9.1 Hz, H-11), 7.96 (1H, d, J = 9.1 Hz, H-12), 8.68 (1H,
s, H-13), 3.99 (3H, s, 2-OCH3), 4.19 (3H, s, 9-OCH3), 4.10
(3H, s, 10-OCH3).
13C NMR (CDCl3, 600 MHz) δ 109.6
(d, C-1), 150.9 (s, C-2), 152.1 (s, C-3), 116.6 (d, C-4), 130.5
(s, C-4a), 27.8 (t, C-5), 57.4 (t, C-6), 145.7 (d, C-8), 122.9
(s, C-8a), 145.9 (s, C-9), 151.5 (s, C-10), 128.1 (d, C-11),
124.2 (d, C-12), 135.7 (s, C12a), 120.2 (d, C-13), 141.1
(s, C-13a), 117.1 (s, C-13b), 56.7 (q, 2-OCH3), 62.4
(q, 9-OCH3), 57.7 (q, 10-OCH3). MS: m/z 338 (28%), 176
(55%), 154 (100%), 77 (29%), 41 (25%). MS exhibited a
molecular ion peak at m/z 338 consistent with the formula
C20H20NO4
+ D.B.E of 11.5 indicating presence of a qua-
ternary ammonium salt. All the data for compound 4
were consistent with the reported values for
jatrorrhizine [35]. Jatrorrhizine (4) has been previously
reported from several plant families: Papaveraceae,
Berberidaceae, Fumariaceae, Menispermaceae, Ranunculaceae,
Rutaceae, Annonaceae, Magnoliaceae and Convolvulaceae
[35].
Columbamine (5): orange solid (34.2 mg, mp. 235–
240°C), 1H NMR (CDCl3, 600 MHz) δ 7.51 (1H, s, H-1),
7.00 (1H, s, H-4), 3.24 (2H, t, J = 6.0 Hz, H-5), 4.92
(2H, t, J = 6.0 Hz, H-6), 9.74 (1H, t, br, s, H-8), 8.10 (1H, d,
J = 9.0 Hz, H-11), 7.99 (1H, d, J = 9.0 Hz, H-12), 8.63 (1H,
s, H-13), 3.95 (3H, s, 2-OCH3), 4.20 (3H, s, 9-OCH3), 4.10
(3H, s, 10-OCH3).
13C NMR (CDCl3, 600 MHz) δ 109.2
(d, C-1), 149.2 (s, C-2), 152.8 (s, C-3), 111.7 (d, C-4), 127.8
(s, C-4a), 27.7 (t, C-5), 57.4 (t, C-6), 146.1 (d, C-8), 123.2
(s, C-8a), 145.5 (s, C-9), 151.7 (s, C-10), 127.8 (d, C-11),
124.3 (d, C-12), 135.2 (s, C12a), 120.8 (d, C-13), 140.0
(s, C-13a), 120.5 (s, C-13b), 57.5 (q, 2-OCH3), 62.4
(q, 9-OCH3), 56.4 (q, 10-OCH3). MS: m/z 338 (28%),
176 (55%), 154 (100%), 77 (29%), 41 (25%). The MS of
columbamine (5) exhibited a molecular ion peak at m/z
338 consistent with the formula C20H20NO4
+ (D.B.E
11.5) confirming the presence of quaternary nitrogen
atom. All the data were consistent with the reported values
for columbamine (5) [35]. Columbamine (5) has been previ-
ously reported from several plant families: Papaveraceae,
Berberidaceae, Fumariaceae, Menispermaceae, Ranunculaceae,
Rutaceae, Annonaceae, Magnoliaceae and Convolvulaceae
[35].
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(28.2 mg, m.p. 204–205°C), 1H NMR (600 MHz,
CD3OD) δ 6.89 (1H, s, H-1), 6.90 (1H, s, H-4), 3.28 (1H,
m, H-5eq), 3.33 (1H, m, H-5ax), 3.60 (1H, m, H-6eq), 3.84
(1H, m, H-6ax), 4.91 (1H, d, J = 15.7, H-8eq), 4.78 (1H, d,
J = 15.7, H-8ax), 7.07 (1H, d, J = 8.5, H-11), 6.98 (1H,
d, J = 8.5, H-12), 3.15 (1H, dd, J = 18, 10.3, H-13ax), 3.50
(1H, dd, J = 18, 5.7, H-13 eq), 4.76 (1H, dd, J = 10.3, 5.7,
H-13a), 3.84 (3H, s, 2-OCH3), 3.85 (3H, s, 3-OCH3), 3.90
(3H, s, 9-OCH3), 3.87 (3H, s, 10-OCH3).
13C NMR
(600 MHz, CD3OD) δ 111.3 (d, C-1), 151.6 (s, C-2), 150.4
(s, C-3), 115.5 (d, C-4), 125.7 (s, C-4a), 24.6 (t, C-5), 53.3
(t, C-6), 61.4 (d, C-8), 121.4 (s, C-8a), 147.1 (s, C-9), 153.1
(s, C-10), 115.0 (d, C-11), 125.0 (d, C-12), 123.7 (s, C12a),
35.4 (d, C-13), 67.7 (s, C-13a), 125.7 (s, C-13b), 53.5
(q, 2-OCH3), 56.4 (q, 3-OCH3), 63.1 (q, 9-OCH3), 56.1
(q, 10-OCH3). The MS of (−)-tetrahydropalmatine (6)
exhibited molecular ion peak at m/z 356 consistent with
the formulae C21H27NO4 (D.B.E 10). The odd molecular
mass confirmed the presence of a neutral alkaloid. Com-
parison of the observed spectral data with literature values for
(−)-tetrahydropalmatine (6) [35]. (−)-Tetrahydropalma
tine (6) has been previously reported from several plant
families: Papaveraceae, Berberidaceae, Fumariaceae,
Menispermaceae, Ranunculaceae, Rutaceae, Annonaceae,
Magnoliaceae and Convolvulaceae [35]. This is the first re-
port on the presence of (−)-tetrahydropalmatine (6) from
Annickia kummeriae (Annonaceae).
Results and discussion
The in vitro anti-plasmodial, anti-trypanosomal, anti-
leishmanial and lower cytotoxicity activity of extracts
from A. kummeriae were previously published elsewhere
[36]. Results of the fractionation of methanolic extract of
A. kummeriae leaves by HSCCC are shown in Table 1.
Of the 17 fractions 8 (47.1%) exhibited very strong anti-
plasmodial activity against P. falciparum K1 strain (IC50
0.05 ± 0.01-0.13 ± 0.02 μg/ml) with excellent selectivity
(SI >692), 3 (17.6%) showed strong activity (IC50 0.45 ±
0.15-0.87 ± 0.1 μg/ml) with satisfactory selectivity (SI
22.9-145.2) while the remaining 6 (35.3%) exhibited
moderate activity (IC50 1.0 ± 0.22-5.0 ± 0.31 μg/ml)
with moderate selectivity (SI 18.0-90.0). The anti-
plasmodial activity (IC50) and cytotoxicity (CC50) of
the 17 HSCCC fractions were compared with the standard
drugs: chloroquine, artemisinin and podophyllotoxin.
Fractions AKLM 9–12 (IC50 0.05 ± 0.01-0.09 ± 0.04 μg/ml,
SI 1,000.0-1,800.0) were of particular interest since the anti-
plasmodial activity compared very well to CQ, and
was only 30-fold lower than that of artemisinin, and
is not cytotoxic. Others with promising anti-plasmodial
activity included: AKLM 8 (0.09 ± 0.004 μg/ml, SI >1,000,
1.4 and 45 fold lower than CQ and artemisinin, respec-
tively), AKLM 16 (IC50 0.09 ± 0.03 μg/ml, SI 933.3, 1.4 and45 fold lower than CQ and artemisinin, respectively),
AKLM 7 (IC50 0.11 ± 0.02 μg/ml, SI >818.2; 1.7 and 55 fold
lower than CQ and artemisinin, respectively), AKLM 15
(IC50 0.13 ± 0.02 μg/ml, SI >692, 2.1 and 65 fold lower
than CQ and artemisinin, respectively) and AKLM 6 (IC50
0.45 ± 0.15 μg/ml, SI 131.1, 7.1 and 225 fold lower than
CQ and artemisinin, respectively) all of which were not
toxic. HSCCC re-fractionation of AKLM 2 (IC50 0.87 ±
0.1 μg/ml, SI 22.9) gave 11 sub-fractions but only two
(AKLM 2.10 and AKLM 2.11 with IC50 0.64 ± 0.34 and
0.89 ± 0.20 μg/ml, respectively) showed moderate anti-
plasmodial activity against P. falciparum K1 strain as the
mother fraction: (Table 2).
In fact the remaining 9 sub-fractions exhibited lower
antiplasmodial activity (IC50 1.09 ± 0.26-5.0 ± 0.53 μg/ml)
and poor to satisfactory selectivity (SI 11.9-72.6) than the
mother fraction. In the comparison of the antiplasmodial
activity (IC50), HSCCC fraction AKLM 2.10 showed 13.9
and 445 fold lower activity than CQ and artemisinin,
respectively) whereas, AKLM 2.11 revealed 10 and 320
fold lower activity than CQ and artemisinin, respectively).
Both fractions were not cytotoxic. The methanolic leaf
extract of A. kummeriae gave four pure alkaloids:
lysicamine (1), trivalvone (2), palmatine (3), jatrorrhizine
(4), and a pair of inseparable mixtures of two alkaloids
each: jatrorrhizine (4)/columbamine (5), and palmatine
(3)/(−)-tetrahydropalmatine (6), which were tested for
anti-plasmodial, anti-trypanosomal, anti-leishmanial and
cytotoxic activity.
Bioassay guided HSCCC fractionation of AKLM 2,
using P. falciparum K1 strain, led to two major alkaloids
lysicamine (1), an aporphine alkaloid and trivalvone (2),
a bis-aporphine alkaloid as confirmed by spectral ana-
lysis. Lysicamine (1) has been widely isolated from
several plant species [30]. However, this is the first re-
port on its isolation from A. kummeriae (Annonaceae).
Trivalvone (2) is a rare bis-aporphine alkaloid first reported
in 1990 from Trivalvaria macrophylla (Annonaceae) [31]
and subsequently from Piptostigma fugax (Annonaceae)
[32]. This is also the first report on its presence in A.
kummeriae (Annonaceae).
Similarly, bioassay-led HSCCC fractionation of the
combined antiplasmodial fractions AKLM 7-AKLM 10,
led to the isolation of two protoberberine alkaloids,
which were confirmed by spectral analysis as palmatine
(3) [10,33-35,37] and jatrorrhizine (4) [34,35,37]. Like-
wise, bioassay-directed HSCCC fractionation of the
combined anti-plasmodial fractions AKLM 4-AKLM 6
yielded an inseparable mixture (1.2:1.0) of proto-
berberine alkaloids, which were confirmed as jatro-
rrhizine (4) [34,35] and columbamine (5) [35,38,39] by
spectral analysis. Bioassay-informed HSCCC fraction-
ation of the anti-plasmodial fraction AKLM 16 gave
an inseparable mixture (1.1:1.0) of protoberberine
Table 1 Anti-plasmodial activity (IC50) and cytotoxicity (CC50) of HSCCC fractions of Annickia kummeriae methanolic
leaf extract
Fraction Wt (mg) P. falciparum K1
IC50 (μg/ml)
Cytotoxicity CC50
(μg/ml)
SI IC50 fr.
IC50 CQ
IC50 fr.
IC50 Art
IC50 fr.
IC50 Pdx
AKLM 15,000 0.12 ± 0.01 30.0 ± 0.8 250 1.9 60 3,333
AKLM1 562 5.0 ± 0.31 >90.0 >18 79.4 2500 >10,000
AKLM2 2,999 0.87 ± 0.1 20.0 ± 3.3 23 13.8 435 2,222
AKLM3 1,534 3.01 ± 0.81 78.0 ± 5.4 26 47.8 1,505 8,667
AKLM 4 157 1.34 ± 0.33 76.0 ± 1.44 57 21.3 670 8,444
AKLM 5 249 3.6 ± 0.2 >90.0 >25 57.1 1,800 >10,000
AKLM 6 427 0.45 ± 0.15 59.0 ± 1.5 131 7.1 225 6,556
AKLM 7 165 0.11 ± 0.02 >90.0 >818 1.7 55 >10,000
AKLM 8 221 0.09 ± 0.04 >90.0 >1,000 1.4 45 >10,000
AKLM 9 680 0.06 ± 0.02 >90.0 >1,500 1.0 30 >10,000
AKLM 10 1,295 0.05 ± 0.02 >90.0 >1,800 0.8 25 >10,000
AKLM 11 1,679 0.05 ± 0.01 >90.0 >1,800 0.8 25 >10,000
AKLM 12 1,056 0.06 ± 0.03 >90.0 >1,500 1.0 30 >10,000
AKLM 13 878 0.62 ± 0.4 >90.0 >145 9.8 310 >10,000
AKLM 14 948 1.0 ± 0.22 >90.0 >90 15.9 500 >10,000
AKLM 15 1,232 0.13 ± 0.02 >90.0 >692 2.1 65 >10,000
AKLM 16 416 0.09 ± 0.03 84.0 ± 3.91 933 1.4 45 9,333
AKLM 17 498 1.67 ± 0.43 >90.0 >54 26.5 835 >10,000
Fr. – HSCCC fraction of Annickia kummeriae leaves methanolic extract, P. falciparum K1 used for anti-plasmodial assays, rat myoblast L-6 cells used for cytotoxicity
assays, CQ chloroquine (IC50 0.063 ± 0.034 μg/ml), Art artemisinin (IC50 0.002 ± 0.00001 μg/ml), Pdx podophyllotoxin (IC50 0.009 ± 0.003 μg/ml).
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firmed a palmatine (3) and (−)-tetrahydropalmatine (6)
[33-35,40,41]. This is the first report on the presence of
columbamine (5) and (−)-tetrahydropalmatine (6) in
A. kummeriae.Table 2 Anti-plasmodial activity (IC50) and cytotoxicity (CC50)
methanolic leaf extract
Fraction Weight (mg) P. falciparum K1
IC50 (μg/ml)
Cytoto
CC50 (μ
AKLM 2 2,500 0.90 ± 0.11 21.0
AKLM 2.1 15.3 5.0 ± 1.31
AKLM 2.2 26.9 1.09 ± 0.26 79.1
AKLM 2.3 57.6 4.11 ± 0.29 53.1
AKLM 2.4 98.7 1.16 ± 0.18 13.8
AKLM 2.5 126.1 3.63 ± 0.04 24.6
AKLM 2.6 115.7 1.23 ± 0.31 39.5
AKLM 2.7 239.0 3.41 ± 0.48 85.4
AKLM 2.8 478.3 5.0 ± 0.53
AKLM 2.9 351.8 2.40 ± 0.57 56.7
AKLM 2.10 301.9 0.89 ± 0.20 35.3
AKLM 2.11 672.8 0.64 ± 0.34 44.7
HSCCC High speed counter current chromatography; AKLM Annickia kummeriae leaf
myoblast L-6 cells used for cytotoxicity assays, CQ chloroquine (IC50 0.063 ± 0.034 μ
(IC50 0.009 ± 0.003 μg/ml).The four pure alkaloids, lysicamine (1), trivalvone (2),
palmatine (3), jatrorrhizine (4) and the two sets of
mixtures of jatrorrhizine (4) with columbamine (5) and
palmatine (3) with (−)-tetrahydropalmatine (6) were
found to exhibit in vitro anti-plasmodial activity againstdata of sub-fractions of fraction 2 of Annickia kummeriae
xicity
g/ml)
SI IC50 fr.
IC50CQ
IC50 fr.
IC50 Art
CC50 fr.
CC50 Pdx
± 3.87 23.3 14 450 3,500
>90 18.0 78 2,500 >15,000
± 7.60 72.6 17 545 13,183
± 9.20 12.9 64 2,055 8,850
± 1.80 11.9 18 580 2,300
± 3.30 6.8 57 1,815 4,100
± 2.20 32.1 19 615 6,583
± 4.60 25.0 53 1,705 14,233
>90 18.0 78 2,500 >15,000
± 8.00 23.6 38 1,200 9,450
± 5.31 39.7 14 445 5,883
± 4.45 69.8 10 320 7,450
methanol extract, P. falciparum K1 used for anti-plasmodial assays, rat
g/ml), Art - artemisinin (IC50 0.002 ± 0.00001 μg/ml), Pdx - podophyllotoxin
Table 3 Anti-protozoal activity (IC50) and cytotoxicity (CC50) data of alkaloids from Annickia kummeriae
P. falciparum K1 T.b. rhodesiense L. donovani L-6 cells
Compound IC50 ±S.E (μg/ml) SI IC50±S.E (μg/ml) SI IC50±S.E (μg/ml) SI CC50 ± S.E (μg/ml)
Lysicamine (1) 2.4 ± 0.642 1.5 3.7 ± 0.001 2.3 2.7 ± 0.001 1.7 1.6 ± 0.01
Trivalvone (2) 1.6 ± 0.232 28.3 14.3 ± 0.001 3.2 2.9 ± 0.001 15.6 45.3 ± 0.02
Palmatine (3) 0.080 ± 0.001 1,154 3.2 ± 0.004 28.1 7.8 ± 0.001 11.5 >90
Jatrorrhizine (4) 0.24 ± 0.002 375.0 4.2 ± 0.002 21.4 20.4 ± 0.03 4.4 >90
Jatrorrhizine (4)/columbamine (5) 0.14 ± 0.017 358.6 4.0 ± 0.001 12.6 13.1 ± 0.02 3.8 50.2 ± 0.08
Palmatine (3)/tetrahydro- palmatine (6) 0.098 ± 0.002 629.6 4.3 ± 0.005 14.4 7.0 ± 0.06 8.81 61.7 ± 0.01
P. falciparum – K1 strain, T. b. rhodesiense – STIB 900 strain, L. donovani - MHOM-ET-67/L82, L-6 - rat skeletal myoblast cells, IC50 – inhibitory concentration for 50%
of tested parasites, CC50 – cytotoxic concentration for 50% of tested cells, chloroquine IC50 0.063 ± 0.03, artemisinin IC50 0.002 ± 0.0001, melarsoprol IC50 0.002 ±
0.0001, miltefosine IC50 0.11 ± 0.001, podophyllotoxin IC50 0.009 ± 0.0003.
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trypanosomal activity against the T. b. rhodesiense STIB
900 and anti-leishmanial activity against L. donovani
axenic MHOM-ET-67/82 strain (Table 3).
Four protoberberine alkaloids showed strong in vitro ac-
tivity against P. falciparum K1 strain (IC50 0.08 ± 0.001-
0.24 ± 0.002 μg/ml) singly and as mixtures and good
selectivity (SI >375) while the remaining two aporphine
alkaloids exhibited moderate anti-plasmodial activity (IC50
1.6 ± 0.23-2.4 ± 0.04 μg/ml) singly and poor to moderate
selectivity (SI 1.6–28.8). Palmatine (3) exhibited the
strongest anti-plasmodial activity against P. falciparum K1
strain (IC50 0.08 ± 0.001 μg/ml) and a good selectivity (SI
1,154). Jatrorrhizine (4) also showed strong anti-
plasmodial activity (0.24 ± 0.002 μg/ml) and good se-
lectisity (SI >375). Protoberberine alkaloids were of
particular interest as they showed strong anti-plasmodial
activity which was very close to that of chloroquine as
shown in Table 4. Our data indicate that, palmatine (3)
and jatrorrhizine (4) with other protoberberine alkaloids
such as columbamine (5) and (−)-tetrahydropalmatine (6)
are active constituents responsible for the antiplasmodial
activity of A. kummeriae. However, the protoberberines
and the monomeric aporphine alkaloids were only moder-
ately active against T. b. rhodesiense STIB 900 strain
in vitro (IC50 2.8 ± 0.001–4.3 ± 0.0005 μg/ml) with mode-
rate selectivity (SI 14.4-28.1) whereas the bis-aporphineTable 4 Comparison of anti-protozoal activity (IC50) and cytot
standard drugs
Compound IC50 cpd IC50 CQ IC50 cpd I
Lysicamine (1) 38.1 1,200.0
Trivalvone (2) 25.4 800.0
Palmatine (3) 1.3 40.0
Jatrorrhizine (4) 3.8 120
Jatrorrhizine (4) + columbamine (5) (1.2:1.0) 2.2 69.0
Palmatine (3) + (−)-tetrahydropalmatine (6)
(1.1:1.0)
1.6 49.0
Cpd isolated compound, CQ chloroquine, Art artemisinin, Mel melarsoprol, Pdx podoalkaloid, trivalvone (2) was inactive (IC50 14.3 ± 0.001 μg/ml).
Similarly, the two aporphine alkaloids showed moderate
activity against L. donovani MHOM-ET-67/L82 axenic
amastigotes in vitro: lysicamine (1) (IC50 2.7 ± 0.0001 μg/ml)
with no selectivity (SI 1.5) and trivalvone (2) (IC50 2.9 ±
0.0001 μg/ml) with moderate selectivity (SI 15.6) while the
remaining four protoberberine alkaloids were inactive (IC50
7.0 ± 0.001-20.4 ± 0.001 μg/ml). Moderate to mild anti-
leishmanial activity (23.6-185.5 folds) was noted for all the
isolated compounds compared to miltefosine (IC50 0.11 ±
0.001 μg/ml) as shown in Table 4.
The literature indicate that plants that contain
protoberberine and aporphine alkaloids are used in
folkloric medicine as anti-hypertensive, anti-cancer, anti-
septic, sedatives, analgesics, anti-inflammatory, anti-
fungal, anti-bacterial and anti-protozoal [21,40]. The
in vitro anti-plasmodial activity of protoberberine
alkaloids has been previously reported. However, none
of them has been shown to be active in vivo [16-19,35].
Oxygenation at C-2, C-3 (ring A) and C-9, C-10 (ring D)
together with the presence of quaternary nitrogen atom
in position 7 in protoberberine alkaloids have already
been identified as the structural motifs required for
strong antiplasmodial activity [42]. The relationship be-
tween the oxygenation and the antiplasmodial activity
provides clues for possible molecular frameworks for
synthesis and structure-activity relationship studiesoxicity (CC50) of alkaloids from Annickia kummeriae with
C50 Art IC50 cpd IC50 Mel IC50 cpd IC50 Milt CC50 cpd CC50 Pdx
1,850.0 23.6 177.8
7,150.0 26.4 5,033.3
1,600.0 70.9 >10,000
2,100.0 185.5 >10,000
2,000.0 119.1 5,577.8
2,150.0 63.64 6,855.6
phyllotoxin.
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phore(s) for new generation of isoquinoline anti-
plasmodial drug(s).Conclusion
To the best of our knowledge, this is the first report on the
anti-plasmodial and anti-leishmanial activity of A. kum-
meriae, in vitro anti-trypanosomal activity of palmatine (3);
anti-plasmodial, anti-trypanosomal, anti-leishmanial and
cytotoxicity activity of trivalvone (2); anti-leishmanial and
anti-trypanosomal activity of jatrorrhizine (4) and of the
two sets of mixtures: jatrorrhizine (4)/columbamine (5)
(1.2:1.0) and palmatine (3)/(−)-tetrahydropalmatine (6)
(1.1:1.0). The present phytochemical and pharmacological
results indicate that A. kummeriae, a traditional remedy
for malaria and fever, exhibits a wide array of biological
activities, which could be attributed to the constituent
aporphine and protoberberine alkaloids. The protober-
berine alkaloids exhibit good antiprotozoal activity in vitro
and comparably low cytotoxicity. In contrast, the activity
and selectivity of aporphine alkaloids is moderate. Given
the reported lack of in vivo activity of protoberberine
alkaloids, further investigations should focus on a better
understanding of their pharmacokinetic properties, and on
possible improvements through synthetic modifications.
Competing interests
The authors declare no competing interests.
Authors’ contributions
HMM conceived the project. HMM, TW, MC, MOO, DH and PD performed the
experiments. IN, SMS, AH, US, MH and RB supervised the work. All authors
evaluated the results and revised the manuscript for publication. All the
authors read and approved the final manuscript.
Acknowledgements
The German Academic Exchange Program (DAAD) for supporting this work
by award of a scholarship grant A/03/44009 to H.M.M. The International
Foundation for Science (IFS) through project grant F/3767-1 and Canton
Basel Stipend Commission for the research visit grant to the Swiss Tropical
and Public Health Institute (STPHI), the Institute of Organic Chemistry at
UNIBAS and the Institute of Pharmaceutical Biology (PharmBio) at UNIBAS in
Swizerland. Extraction and initial isolation of compounds was carried out at
the Department of Traditional Medicine at the National Institute for Medical
Research (NIMR) in Tanzania and the Department of Chemistry at Kenyatta
University in Kenya. NIMR, the Institute of Organic Chemistry (UNIBAS),
PharmBio (UNIBAS) and the STPHI are gratefully acknowledged for provision
of laboratory space, supervison and financially supported this project.
Author details
1Department of Traditional Medicine Research, National Institute for Medical
Research, P.O. Box 9653, Dar es Salaam, Tanzania. 2Medical Parasitology and
Infection Biology, Parasite Chemotherapy Unit, Swiss Tropical Institute,
University of Basel, Socinstrasse 57, CH-4002, Basel, Switzerland. 3Department
of Chemistry, Kenyatta University, P.O. Box 43844, Nairobi, Kenya.
4International Centre for Insect Physiology and Ecology, P.O. Box 30772,
Nairobi, Kenya. 5Institute of Organic Chemistry, University of Basel, St Johanns
Ring 19, CH-4052, Basel, Switzerland. 6Institute of Pharmaceutical Biology,
University of Basel, Klingelbergstrasse 50, CH-4056, Basel, Switzerland.
7Department of Pure and Applied Chemistry, Masinde Muliro University of
Science & Technology, P. O. Box 190, Kakamega, Kenya.Received: 29 October 2012 Accepted: 4 February 2013
Published: 27 February 2013References
1. WHO. The World Health Report: Reducing Risks, Promoting Healthy Life.
Geneva: WHO; 2002.
2. WHO: Chemical Methods for Control of Arthropod Vectors and Pests of Public
Health. Geneva, Switzerland: WHO; 1984.
3. Marsden PD: American trypanosomiasis. In Manson’s Tropical Diseases, 64. 20th
edition. Edited by Cook G. New Delhi: W.B. Saunders & Co; 1996:1197–1212.
4. Bryceson ADM: Leishmaniasis. In Manson’s Tropical Diseases, 65. 20th
edition. Edited by Cook G. New Delhi: W. B. Suanders & Co; 1996:1213–1245.
5. Olliaro P, Cattani J: Malaria, the submerged disease. J Am Med Assoc 1996,
275:230.
6. Sandberg F, Cronlund A: What can we still learn from traditional folklore
medicine? Examples from the results of a biological screening of medicinal
plants from equatorial Africa, Volume 3. Colombo, Sri Lanka: Proc. 3rd Asian
Symposium on Medicinal Plants and Spices; 1977:178–197.
7. Newman DJ, Cragg GM, Snader KM: The influence of natural products
upon drug discovery. Nat Prod Rep 2000, 17:215–234.
8. Betti JL: Medicinal plants sold in Yaoundé markets, Cameroon. African
Study Monographs 2002, 23:47–64.
9. Bouquet A, Debray M: Plantes médicinales de la Côte d’Ivoire, Volume 32.
Paris: Mémoires Office de la Recherche Scientifique et Technique d'Outre-
Mer (O.R.S.T.O.M); 1974:232.
10. Wafo P, Nyasse B, Fontaine C, Sondengam BL: Aporphine alkaloids from
Enantia chlorantha. Fitoterapia 1999, 70:157–160.
11. Atindehou KK, Schmid C, Brun R, Koné MW, Traore D: Anti-trypanosomal
and anti-plasmodial activity of medicinal plants from Côote d’Ivoire.
J Ethnopharmacol 2004, 90:221–227.
12. Agbaje EO, Onabanjo AO: The effects of extracts of Enantia chlorantha in
malaria. Ann Trop Med Parasitol 1991, 85:585–590.
13. Leboeuf M, Cave A: Alcalöides des Annonacées. Plantes Médicinales et
Phytothérapie 1972, 6:87–90.
14. Jössang A, Leboeuf M, Cave A: Alcalöides des Annonacées. XVII. Alcalöides
de l’Enantia polycarpa Engl. et Diels. Planta Med 1977, 32:249–257.
15. Jössang A, Leboeuf M, Cave A: La polycarpine, nouvelle alcalöide
isoquinolique de l’Enantia polycarpa Engler et Diels. Comptes Rendus de
l’Académie des Sciences 1977, 284:567–569.
16. Buzas A, Osowiecki M, Regnier C: Sur la présence de quinidine (et
l’hydroquinidine) dans l’écorce de l’Enantia polycarpa. Comptes Rendus
Académie des Sciences 1959, 248:2791–2793.
17. Buzas A, Egnell C, Orsay F: Sur la présence de quinidine à côté
d’alcaloïdes berberiniques dans les écorces d’Enantia pilosa et E.
polycarpa. Annales Pharmaceutiques de France 1965, 23:351–354.
18. Vennerstrom JL, Klayman DL: Protoberberine alkaloids as antimalarials.
J Med Chem 1988, 31:1087–1093.
19. Phillipson JD, Wright CW: Antiprotozoal agents from plant sources. Planta
Med 1991, 57:53–59.
20. Virtanen P, Lassila V, Njimi T, Mengata DE: Natural protoberberine alkaloids
from Enantia chlorantha, palmatine, columbamine and jatrorrhizine for
thioacetamide-traumatized rat liver. Acta Anatomy (Basel) 1988, 131:166–170.
21. Guo Y, Kojima K, Lin L, Fu X, Zhao C, Hatano K, Chen Y-J, Ogihara Y: A new
N-methyltetrahydroprotoberberine alkaloids from Tinospora hainanensis.
Chem Pharm Bull 1999, 47:287–289.
22. Trager W, Jenssen JB: Human malaria parasites in continuous culture.
Science 1976, 193:673–675.
23. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD: Quantitative assessment
of antimalarial activity in vitro by a semi-automated microdilution
technique. Antimicrob Agents Chemother 1979, 16:710–718.
24. Matile H, Pink JRL: Plasmodium falciparum malaria parasite cultures and
their use in immunology. In Immunological Methods. Edited by Lefkovits I,
Pernis B. Academic Press: San Diego; 1990:221–234.
25. Baltz T, Baltz D, Giroud C, Crockett J: Cultivation in a semi-defined
medium of animal infective forms of Trypanosoma brucei, T.
equiperdum, T. evansi, T. rhodesiense and T. gambiense. EMBO J 1985,
4:1273–1277.
26. Räz B, Iten M, Grether-Bühler Y, Kaminsky R, Brun R: The Alamar Blue assay
to determine drug sensitivity of African trypanosomes (T. b. rhodesiense
and T. b. gambiense). Acta Trop 1997, 68:139–147.
Malebo et al. BMC Complementary and Alternative Medicine 2013, 13:48 Page 10 of 10
http://www.biomedcentral.com/1472-6882/13/4827. Ganapaty S, Thomas PS, Karagianis G, Waterman PG, Brun R: Antiprotozoal
and cytotoxic naphthalene derivatives from Diospyros assimilis.
Phytochem 2006, 67:1950–1956.
28. Tsai TH, Wang GJ, Lin LC: Vasorelaxing alkaloids and flavonoids from
Cassytha filiformis. J Nat Prod 2008, 71:289–291.
29. Katsui N, Sato K: Alkaloids of Lysichton camtschatcense Schott var.
Japonicum Makino. Tetrahedron Letters 1966, 50:6257–6261.
30. Chang Y-C, Chang FR, Wu Y-C: The constituents of Lindera glauca. J Chin
Chem Soc 2000, 47:373–380.
31. Cortes D, Davoust D, Hadi AHA, Myint SH, Hoquemiller R, Cave A:
Trivalvone, une nouvelle bis-aporphine des ecorces de Trivalvaria
macrophylla. J Nat Prod 1990, 53:862–866.
32. Achenbach H, Schwinn A: Aporphinoid alkaloids and terpenoids from
Piptostigma fugax. Phytochem 1995, 38:1037–1048.
33. Halbsguth C, Meiβner O, Häberlein H: Positive cooperation of
protoberberine type 2 alkaloids from Corydalis cava on the GABAA
binding site. Planta Med 2003, 69:305–309.
34. Li C-Y, Lu H-J, Lin C-H, Wu T-S: A rapid and simple determination of
protoberberine alkaloids in cortex phellodendri by 1H NMR and its
application for quality control of commercial traditional Chinese
medicine prescriptions. J Pharm Biomed Anal 2006, 40:173–178.
35. Grycová L, Dostál J, Marek R: Review: Quaternary protoberberine alkaloids.
Phytochemistry 2007, 68:150–175.
36. Malebo HM, Tanja W, Cal M, Swaleh SM, Omolo MO, Hassanali A, Séquin U,
Hamburger M, Ndiege IO, Brun R: Anti-plasmodial, anti-trypanosomal,
anti-leishmanial and cytotoxicity activity of selected Tanzanian medicinal
plants. Tanzania J Heal Res 2009, 11(4):226–234.
37. Muhie S: Chemical Investigations for Anti-malarial and Anti-trypanosomal and
other Chemical Constituents of Uvaria lucida Lucida and Enantia kummeriae.
M.Sc. Thesis. Tanzania: University of Dar-es-Salaam; 1996.
38. Rasoanaivo P, Ratsimamanga-Urverg S, Rakoto-Ratsimamanga A,
Raharisololalao A: Constituants chimiques de trois especes de Burasaia
(Menispermacees) endemiques de Madagascar. Biochem Syst Ecol 1991,
19:433–437.
39. Hsieh TJ, Chia YC, Wu YC, Chen CY: Chemical constituents from the stems
of Mahonia japonica. J Chin Chem Soc 2004, 51:443–446.
40. Hussain RA, Kim J, Beecher CWW, Kinghorn D: Unambiguous carbon-13
NMR assignments of some biologically active protoberberine alkaloids.
Heterocycles 1989, 29:2257–2260.
41. Blanchfield JT, Sands DPA, Kennard CHL, Karl A, Byriel KA, Kitching W:
Characterisation of alkaloids from some Australian Stephania
(Menispermaceae) species. Phytochem 2003, 63:711–720.
42. Iwasa K, Nishiyama Y, Ichimaru M, Moriyasu M, HyeSook K, Wataya Y, Yamori
T, Takashi T, Lee D: Structure-activity relationships of quaternary
protoberberine alkaloids having an antimalarial activity. Eur J Med Chem
1999, 34:1077–1083.
doi:10.1186/1472-6882-13-48
Cite this article as: Malebo et al.: Anti-protozoal activity of aporphine
and protoberberine alkaloids from Annickia kummeriae (Engl. & Diels)
Setten & Maas (Annonaceae). BMC Complementary and Alternative
Medicine 2013 13:48.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
